Withdrawal Versus Continued TNF Inhibitor Monotherapy Treatment in Children With Inactive Juvenile Idiopathic Arthritis

​ Conditions: Juvenile Idiopathic Arthritis (JIA)

Interventions: Drug: Adalimumab; Drug: Etanercept; Drug: Golimumab; Drug: Adalimumab; Drug: Etanercept; Drug: Golimumab

Sponsors: Oslo University Hospital; South-Eastern Norway Regional Health Authority; The Norwegian Rheumatism Association

Not yet recruiting Conditions: Juvenile Idiopathic Arthritis (JIA)
Interventions: Drug: Adalimumab; Drug: Etanercept; Drug: Golimumab; Drug: Adalimumab; Drug: Etanercept; Drug: Golimumab
Sponsors: Oslo University Hospital; South-Eastern Norway Regional Health Authority; The Norwegian Rheumatism Association
Not yet recruiting